Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Biophytis enters loan agreement with Kreos Capital

Executive Summary

Biophytis SA (therapies for age-related degenerative diseases) entered into a €10mm ($11.6mm) bond financing with Kreos Capital. The 10% senior unsubordinated loan will be paid in four equal tranches of €2.5mm--the first two by the end of this month, another by year-end, and the final tranche before June 2019. Biophytis will use the proceeds to prepare for clinical development of its Duchenne myopathy candidate Myoda.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Nonconvertible Debt

Related Companies